FAKTOR-OPTIONSSCHEIN - BECTON DICKINSON AND CO. Stock

Certificat

DE000MC2VTT3

Market Closed - Börse Stuttgart 03:03:14 2024-06-14 pm EDT
0.157 EUR +3.29% Intraday chart for FAKTOR-OPTIONSSCHEIN - BECTON DICKINSON AND CO.
Current month+5.37%
1 month-7.10%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-14 0.157 +3.29%
24-06-13 0.152 -5.00%
24-06-12 0.16 -4.19%
24-06-11 0.167 -6.70%
24-06-10 0.179 -3.76%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 03:03 pm EDT

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN MC2VTT
ISINDE000MC2VTT3
Date issued 2019-07-25
Strike 185.6 $
Maturity Unlimited
Parity 282.78 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 13.34
Lowest since issue 0.129
Spread 0.001
Spread %0.63%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
233.7 USD
Average target price
279.2 USD
Spread / Average Target
+19.45%
Consensus